Longer term patient management following stroke: A systematic review.
Stroke
complication
disease management
follow-up
post-stroke care
review
Journal
International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
pubmed:
6
5
2021
medline:
12
11
2021
entrez:
5
5
2021
Statut:
ppublish
Résumé
Tremendous progress in acute stroke therapy has improved short-term outcome but part of this achievement may be lost in the long run. Concepts for a better long-term management of stroke survivors are needed to address their unmet needs and to reduce the burden of post-stroke complications, residual deficits, and recurrent vascular events. This review summarizes current knowledge on post-hospital care and the scientific evidence supporting individual programs. A systematic search of electronic databases according to PRISMA guidelines identified 10,374 articles, 77 of which met the inclusion criteria. One large randomised controlled trial on a multifaceted care program delivered by the multidisciplinary stroke team reduced recurrent vascular events and improved quality of life and functional outcome one year after the event, while a number of studies offer solutions for individual components of post-hospital disease management like patient education, counselling, and self-management or the management of post-stroke complications and residual deficits. A majority of studies, however, was small in size and limited by a short follow-up. Most initiatives with a narrow focus on risk factor control failed to lower the risk of recurrent events. The caregivers' central role in post-stroke patient management is broadly neglected in research. Over the past years, first knowledge on how to best organize post-hospital care of stroke patients has emerged. Comprehensive and pragmatic programs operated by the multidisciplinary stroke team hold promise to reduce the long-term health burden of stroke. There is a clear need for further high-quality studies with both clinical endpoints and patient-reported outcomes to establish sustainable solutions in different settings and regions to improve life after stroke, a key priority of the Stroke Action Plan for Europe 2018-2030.
Sections du résumé
BACKGROUND
Tremendous progress in acute stroke therapy has improved short-term outcome but part of this achievement may be lost in the long run. Concepts for a better long-term management of stroke survivors are needed to address their unmet needs and to reduce the burden of post-stroke complications, residual deficits, and recurrent vascular events.
AIMS
This review summarizes current knowledge on post-hospital care and the scientific evidence supporting individual programs.
SUMMARY OF REVIEW
A systematic search of electronic databases according to PRISMA guidelines identified 10,374 articles, 77 of which met the inclusion criteria. One large randomised controlled trial on a multifaceted care program delivered by the multidisciplinary stroke team reduced recurrent vascular events and improved quality of life and functional outcome one year after the event, while a number of studies offer solutions for individual components of post-hospital disease management like patient education, counselling, and self-management or the management of post-stroke complications and residual deficits. A majority of studies, however, was small in size and limited by a short follow-up. Most initiatives with a narrow focus on risk factor control failed to lower the risk of recurrent events. The caregivers' central role in post-stroke patient management is broadly neglected in research.
CONCLUSIONS
Over the past years, first knowledge on how to best organize post-hospital care of stroke patients has emerged. Comprehensive and pragmatic programs operated by the multidisciplinary stroke team hold promise to reduce the long-term health burden of stroke. There is a clear need for further high-quality studies with both clinical endpoints and patient-reported outcomes to establish sustainable solutions in different settings and regions to improve life after stroke, a key priority of the Stroke Action Plan for Europe 2018-2030.
Identifiants
pubmed: 33949269
doi: 10.1177/17474930211016963
pmc: PMC8554494
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
917-926Références
Cerebrovasc Dis. 2008;25(5):423-9
pubmed: 18349536
Stroke. 2017 Sep;48(9):2504-2510
pubmed: 28754834
N Engl J Med. 2018 Dec 20;379(25):2429-2437
pubmed: 30575491
Stroke. 2019 Mar;50(3):705-712
pubmed: 30802185
J Clin Nurs. 2007 Feb;16(2):272-81
pubmed: 17239062
Lancet Neurol. 2020 Jan;19(1):49-60
pubmed: 31708447
Health Educ Res. 2013 Jun;28(3):488-501
pubmed: 23515115
Lancet Neurol. 2019 May;18(5):459-480
pubmed: 30879893
CMAJ. 2014 May 13;186(8):577-84
pubmed: 24733770
Stroke. 2015 Dec;46(12):3451-8
pubmed: 26508749
JAMA. 2015 Apr 14;313(14):1451-62
pubmed: 25871671
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
Int J Stroke. 2020 Dec;15(9):954-964
pubmed: 32293236
J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105482
pubmed: 33253985
Stroke. 2016 Jul;47(7):1885-92
pubmed: 27301941
Cerebrovasc Dis. 2013;36(2):88-97
pubmed: 24029303
Eur J Prev Cardiol. 2015 Oct;22(10):1354-62
pubmed: 25139770
J Neurol Neurosurg Psychiatry. 2009 Mar;80(3):279-84
pubmed: 19010943
Eur J Neurol. 2017 Jul;24(7):920-928
pubmed: 28488353
BMJ Open. 2020 Jun 11;10(6):e035850
pubmed: 32532772
BMJ. 2008 Feb 16;336(7640):376-9
pubmed: 18230644
Stroke. 2007 Jun;38(6):1899-904
pubmed: 17510453
BMC Neurol. 2018 Sep 21;18(1):153
pubmed: 30241499
Neurology. 2019 Dec 3;93(23):e2121-e2132
pubmed: 31672716
Stroke. 2020 Nov;51(11):3452-3460
pubmed: 33070713
EClinicalMedicine. 2020 Jul 28;25:100476
pubmed: 32954239
Stroke. 2014 Nov;45(11):3330-6
pubmed: 25248910
Cochrane Database Syst Rev. 2018 May 07;5:CD009103
pubmed: 29734470
Ann Intern Med. 2005 Nov 1;143(9):659-72
pubmed: 16263889
Stroke. 2018 Feb;49(2):426-432
pubmed: 29284737
PLoS One. 2015 Oct 16;10(10):e0139997
pubmed: 26474055
Lancet Oncol. 2017 Jan;18(1):e19-e29
pubmed: 28049574
Stroke. 2014 Feb;45(2):515-9
pubmed: 24385269
Stroke. 2017 Jan;48(1):174-179
pubmed: 27924055
J Stroke Cerebrovasc Dis. 2011 Jan-Feb;20(1):16-23
pubmed: 21187254
Stroke. 2015 Oct;46(10):2874-80
pubmed: 26374482
J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e173-80
pubmed: 23265778
Eur Stroke J. 2018 Dec;3(4):309-336
pubmed: 31236480
Stroke. 2010 Nov;41(11):2470-6
pubmed: 20864664
Clin Rehabil. 2019 Feb;33(2):262-276
pubmed: 30409049
BMC Neurol. 2017 Jul 17;17(1):133
pubmed: 28716014
Lancet Neurol. 2015 Jan;14(1):48-56
pubmed: 25435129
Lancet. 2013 Dec 21;382(9910):2069-76
pubmed: 24054816
Int J Stroke. 2020 Jun;15(4):438-453
pubmed: 30785379
Brain Behav. 2016 Apr 28;6(5):e00455
pubmed: 27257517
Int J Stroke. 2014 Oct;9(7):932-8
pubmed: 23205666